Objectives Systemic inflammation is increasingly being recognised as a possible
mechanism for acute arterial thrombotic events, including acute coronary syndrome (ACS) …

Objective To investigate the risk of DM and evaluate the impact of SLE therapies on the risk
of developing DM in patients with SLE. Methods Electronic database searches of PubMed …

Several agents are approved for the treatment of systemic lupus erythematosus (SLE),
including the novel monoclonal antibody belimumab, a B lymphocyte stimulator-specific …

Background/Objectives: This study aims to investigate the long-term effect of inactive
systemic lupus erythematosus (SLE) on the retinal microcirculation measured via optical …

Objectives Systemic inflammation is increasingly being recognised as a possible
mechanism for acute arterial thrombotic events, including acute coronary syndrome (ACS) …

Objective Characterize incident heart failure (HF) phenotypes among patients with various
chronic inflammatory diseases (CIDs). Background Several CIDs are associated with …

BACKGROUND Inflammatory bowel disease (IBD) is an autoimmune condition treated with
immunosuppressive drugs. However, the need for immune system suppression becomes …

Background: Crohn's disease (CD) It is a chronic inflammation that occurs in the digestive
system. This disease is widespread in developing countries. Aim of study: To estimation the …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical
manifestations and organ involvement. Despite significant advancements in understanding …

Objectives: Identify when to consider systemic lupus erythematosus on the differential
diagnosis. Describe the evaluation of systemic lupus erythematosus. Explain the treatment …